Gert Schaart Selected Research

etomoxir

1/2014	Lack of UCP3 does not affect skeletal muscle mitochondrial function under lipid-challenged conditions, but leads to sudden cardiac death.
7/2012	Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gert Schaart Research Topics

Disease

33	Insulin Resistance 01/2021 - 12/2005
17	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2002
6	Obesity 01/2021 - 02/2010
4	Glucose Intolerance 11/2019 - 04/2006
3	Overweight 01/2020 - 04/2011
3	Prediabetic State (Prediabetes) 01/2019 - 06/2010
3	Body Weight (Weight, Body) 07/2012 - 04/2011
3	Glycogen Storage Disease Type II (Pompe's Disease) 02/2008 - 06/2002
2	Hyperglycemia 01/2016 - 06/2010
2	Ischemia 08/2012 - 04/2010
2	Hyperinsulinism (Hyperinsulinemia) 06/2010 - 12/2005
1	Optic Atrophy 01/2021
1	Weight Gain 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2020
1	Ventricular Tachycardia 01/2014
1	Heart Failure 01/2014
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2014
1	Neutral Lipid Storage Disease with Myopathy 03/2013
1	Hypoxia (Hypoxemia) 02/2013
1	Lipoma (Lipomata) 08/2012
1	Fibrosis (Cirrhosis) 08/2012
1	Necrosis 08/2012
1	Hypothermia 07/2012
1	Reperfusion Injury 04/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2010
1	Muscle Weakness 02/2008
1	Inflammation (Inflammations) 08/2007
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2007
1	Sepsis (Septicemia) 10/2006
1	Cachexia 10/2006
1	Myopathy with Abnormal Lipid Metabolism 12/2003

Drug/Important Bio-Agent (IBA)

18	LipidsIBA 01/2021 - 07/2006
13	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2010
11	Insulin (Novolin)FDA Link 01/2021 - 12/2005
7	Fatty Acids (Saturated Fatty Acids)IBA 05/2016 - 12/2003
6	Triglycerides (Triacylglycerol)IBA 05/2014 - 12/2005
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2009
3	ResveratrolIBA 01/2021 - 12/2016
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020 - 11/2019
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 04/2011
2	GlycogenIBA 01/2020 - 06/2002
2	etomoxirIBA 01/2014 - 07/2012
2	Perilipin-2IBA 11/2012 - 10/2009
2	HexokinaseIBA 08/2012 - 04/2010
2	DiglyceridesIBA 07/2012 - 01/2011
2	Uncoupling Protein 3IBA 06/2010 - 10/2002
2	alpha-Glucosidases (Acid Maltase)IBA 04/2006 - 06/2002
2	AcidsIBA 04/2006 - 06/2002
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Chaperonin 60IBA 01/2021
1	Phytosterols (Plant Sterols)IBA 08/2020
1	LDL CholesterolIBA 08/2020
1	ClenbuterolIBA 01/2020
1	HSP72 Heat-Shock ProteinsIBA 01/2020
1	Glucose Transporter Type 4IBA 11/2019
1	phospholipid emulsion soybean oil (Intralipid)IBA 11/2019
1	Acetylcarnitine (Alcar)IBA 11/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	Perilipin-5IBA 01/2018
1	Pharmaceutical PreparationsIBA 12/2016
1	GenisteinIBA 03/2016
1	Messenger RNA (mRNA)IBA 01/2015
1	BezafibrateIBA 03/2013
1	Carbonic Anhydrase IXIBA 02/2013
1	des-Arg-(77)- complement C3aIBA 01/2013
1	Uncoupling Protein 1IBA 07/2012
1	Ethylene Oxide (Oxirane)IBA 07/2012
1	C-Reactive ProteinIBA 04/2011
1	EnzymesIBA 04/2011
1	Dietary Fats (Dietary Fat)IBA 01/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2010
1	AMP-Activated Protein KinasesIBA 02/2010
1	Thioctic Acid (Lipoic Acid)IBA 02/2010
1	PerilipinsIBA 10/2009
1	Cell Adhesion MoleculesIBA 08/2007
1	NF-kappa B (NF-kB)IBA 08/2007
1	Transcription Factors (Transcription Factor)IBA 08/2007
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2006
1	ZymosanIBA 10/2006
1	Rosiglitazone (Avandia)FDA Link 04/2006
1	Oxidoreductases (Dehydrogenase)IBA 12/2003
1	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2003

Therapy/Procedure

4	Therapeutics 01/2018 - 12/2005
1	Caloric Restriction 07/2012
1	Enzyme Therapy 02/2008
1	Enzyme Replacement Therapy 02/2008